LVPEI’s novel stem cell therapy received a patent
Published 30th May 2024
The L V Prasad Eye Institute (LVPEI), Hyderabad, has been granted a patent for a novel cell therapy that can be used to repair damaged corneas from a variety of corneal diseases. The patented therapy uses a unique composition of stem cells derived from the eye’s surface and two clotting factors layered together. This patent has been granted by the Patent Office, Government of India, for 20 years by the provisions of the Patents Act of 1970.
The patent was granted to two LVPEI inventors:
Dr Sayan Basu, a corneal surgeon and a clinician-scientist, is the Prof. D Balasubramanian Chair of Eye Research at the Brien Holden Eye Research Centre (BHERC) and the Director of the Centre for Ocular Regeneration (CORE) at LVPEI.
Dr Vivek Singh, scientist at the Sudhakar and Sreekanth Ravi Stem Cell Biology Laboratory and Centre for Ocular Regeneration (CORE), LVPEI.
